The Global Health Body Issues Alert Over Severe Shortage of Obesity Injections
Under a tenth of individuals that would benefit from GLP-1 drugs such as Wegovy can access them, caution the World Health Organization as it publishes its inaugural recommendations on the therapies.
Given in excess of 1,000,000,000 individuals worldwide now obese, it is advocating for increased and just access to GLP-1 medication.
According to projections, over two billion will be obese by 2030 without intervention.
"The latest guidelines affirms that excess weight is a lifelong illness that can be addressed with comprehensive and continuous care," remarked the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and logistical bottlenecks are key hurdles to widespread availability to the jabs that can aid individuals in losing substantial body mass, says the organization.
GLP-1 Therapy Supply Crisis
Even under the current best projected outlook, the production of GLP-1 therapies could only cover about 100 million people – under 10% of the global need, per the health organization.
The advice encourages countries and companies to expand availability, by approaches including patent sharing.
The intellectual property rights on the active ingredient – the main component of Novo Nordisk's Wegovy – is scheduled to end in multiple nations in 2026.
The Way Obesity Drugs Function
The injections imitate a body's own hormone to slow digestion, suppress the appetite and boost the sense of being full so individuals eat less.
People commonly see weight reduction within a few weeks of commencing the once-weekly jabs.
Studies points to patients may regain a significant portion after a year of stopping the treatment, as their typical food cravings resume.
To be carrying excess weight raises your likelihood for developing health problems, including type 2 diabetes, heart disease, brain attack, and specific malignancies.
Obesity concerns individuals in every country and was responsible for over three and a half million deaths worldwide in 2024, as per the WHO.
